Abstract
New hope for a microRNA therapy for pulmonary arterial hypertension
Highlights
An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension by Kim, J., Kang, Y., Kojima, Y., Lighthouse, J
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by pulmonary vascular remodeling and right heart failure
PAH demonstrates muscularization of distal pulmonary arterioles, concentric thickening, and obstruction of vascular lumen due to the proliferation of pulmonary artery endothelial cells (PAECs) and pulmonary artery smooth muscle cells (PASMCs) (Steiner et al, 2009). Such arteriopathy in PAH leads to a life threatening increase in resistance of PAECs and PASMCs to apoptosis
Summary
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by pulmonary vascular remodeling and right heart failure. An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension by Kim, J., Kang, Y., Kojima, Y., Lighthouse, J. This pathogenesis of PAH shares similarities with cancer, in which angiogenesis is characterized by an increase in proliferating endothelial cells and atypical morphology of tumor vasculature (Hoff and Machado, 2012).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have